24675041 |
The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer
Sun, F,
Crystal, AS,
Awad, MM,
Li, N,
Friboulet, L,
Michellys, PY,
Kasibhatla, S,
Lee, CC,
Shaw, AT,
Li, J,
Harris, JL,
Engelman, JA,
Kim, S,
Lockerman, EL,
Yanagitani, N,
Mahmood, S,
Nishio, M,
McNamara, P,
Pferdekamper, AC,
Hua, S,
Fujita, N,
Gainor, JF,
Sun, X,
Katayama, R
|
Cancer Discov |
2014 |
27432227 |
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
Mino-Kenudson, M,
Friboulet, L,
Benes, CH,
Engelman, JA,
Yoda, S,
DiCecca, RH,
Digumarthy, S,
Le, LP,
Ritterhouse, LL,
Lennerz, J,
Sequist, LV,
Muniappan, A,
Parks, M,
Gainor, JF,
Schultz, K,
Dardaei, L,
Huynh, T,
Iafrate, AJ,
Keyes, C,
Dias-Santagata, D,
Heist, RS,
Shaw, AT,
Singh, M,
Logan, J,
Dagogo-Jack, I,
Leshchiner, I,
Channick, C,
Lee, D,
Chin, E,
Lockerman, E,
Getz, G,
Gadgeel, S,
Katayama, R
|
Cancer Discov |
2016 |